shortagewatch

Home / Anti-infectives / Abacavir

ATC J05AF06 · Nucleoside and Nucleotide Reverse Transcriptase Inhibitors

Abacavir shortage

As of 2 Nov 2026, Abacavir has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.

Countries1/16
Products1packs or presentations
Companies10 listed
Short since27 Jul 20263 months ago
Earliest return31 Jan 2027company estimate
Main reasonManufacturing problem
United StatesNo reported shortageCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageNew ZealandNo reported shortageAustraliaNo reported shortage

Timeline

Canada
2027MINT-ABACAVIR (60 count bottles)MINT-ABACAVIR (60 count bottles)today

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Mint Pharmaceuticals1

Compared with similar medicines

ATC group J05AF · Nucleoside and Nucleotide Reverse Transcriptase Inhibitors
Entecavir8/16Tenofovir Disoproxil6/16Lamivudine3/16Emtricitabine2/16Abacavir1/16Adefovir Dipivoxil1/16

Affected products

CountryProductCompanySinceExpected backReason
CAMINT-ABACAVIR (60 count bottles)MINT PHARMACEUTICALS INC27 Jul 202631 Jan 2027Manufacturing problem
Disruption of the manufacture of the drug

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.